|
|
||||||||
Ann Thorac Surg 1980;29:109-112
© 1980 The Society of Thoracic Surgeons
Department of Surgery, the University of New Mexico School of Medicine, and the Veterans Administration Hospital, Albuquerque, NM
Accepted for publication May 22, 1979.
* Address reprint requests to Dr. Akl, Department of Surgery, University of New Mexico School of Medicine, Albuquerque, NM 87131
This study was done to assess the adequacy of a regimen using cefazolin as a prophylactic antibiotic for patients undergoing open-heart operation. At the time of the preoperative medication, adult patients received 1 gm of cefazolin intramuscularly, and pediatric patients were given a dose of 20 mg per kilogram of body weight. Group I consisted of 10 adults undergoing a variety of cardiac procedures. The mean serum cefazolin level after institution of cardiopulmonary bypass was 27.36 µg/ml (range, 13.1 to 40.3 µg/ml). This level remained fairly stable throughout cardiopulmonary bypass. Group II consisted of 10 pediatric patients undergoing cardiac procedures for repair of a variety of congenital anomalies. The mean serum cefazolin level after institution of cardiopulmonary bypass was 20.01 µg/ml (range, 11.4 to 28.9 µg/ml) and remained stable for the duration of the procedure. In both groups perfusion pressure, urinary output, and body temperature did not seem to have any influence on these levels.
It is concluded that the administration of one dose of cefazolin intramuscularly before operation results in an adequate and stable serum cefazolin level in patients undergoing cardiopulmonary bypass for up to three hours, possibly longer.
This article has been cited by other articles:
![]() |
M. H. Nguyen, S. J. Eells, J. Tan, C. T. Sheth, B. Omari, M. Flores, J. Wang, and L. G. Miller Prospective, Open-Label Investigation of the Pharmacokinetics of Daptomycin during Cardiopulmonary Bypass Surgery Antimicrob. Agents Chemother., June 1, 2011; 55(6): 2499 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Lehot Cefazolin prophylaxis during cardiac operations Ann. Thorac. Surg., February 1, 2004; 77(2): 755 - 756. [Full Text] [PDF] |
||||
![]() |
E. K. Fellinger, B. J. Leavitt, and J. C. Hebert Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery Ann. Thorac. Surg., October 1, 2002; 74(4): 1187 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lonsky, J. Mandak, V. Lonska, V. Rozsival, D. Markova, and J. Kubicek Serum oxacillin and cephazolin levels during cardiopulmonary bypass Perfusion, April 1, 1992; 7(2): 115 - 118. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |